Fertility Preservation Options for the Oncology Patient

September 3, 2020

Walgreens and AllianceRx Walgreens Prime are proud to present Fertility Preservation Options for the Oncology Patient at ONS Bridge 2020. Please mark your calendar for Thursday, September 10 from 2 to 2:45 pm to attend this informative discussion.

Presenter Ann Scalia, BSN, RN, CNOR and director, clinical education, AllianceRx Walgreens Prime, will explore the expanding field of fertility preservation and oncofertility. Oncofertility is an interdisciplinary field at the intersection of oncology and reproductive medicine that increases fertility options for cancer patients. Fertility preservation has become important due to increased survival rates, yet barriers to treatment remain, including a lack of awareness of options, failure to be presented with options, stage of cancer and cost of treatment.

Among other topics, Ann will discuss:

·       The common reproductive concerns that arise when people receive a cancer diagnosis

·       The biological effects that cancer treatment can have on various aspects of reproduction

·       The various technologies available for fertility preservation and how they are used

·       How medical professionals can facilitate needs of patients who are interested in preserving fertility

Please join us on Thursday, September 10. We look forward to seeing you at the presentation.

Walgreens and AllianceRx Walgreens Prime provide specialty medication and comprehensive services to  patients across the country. Walgreens offers 300+ community-based specialty pharmacies and 1,000+ disease state-specialized pharmacies nationwide. AllianceRx Walgreens Prime, formed through a collaboration between Walgreens and Prime Therapeutics, offers six central fill specialty pharmacy and home delivery facilities.

For more information, visit Walgreens.com/Onc or alliancerxwp.com/business/providers